Similarly, abnormally high cell-free DNA (cfDNA) activates TLR9 in immune cell endosomes (92), illustrating that cfDNA undoubtedly becomes a breakthrough in the treatment of RA. The gene discussed is TLR9; the disease is rheumatoid arthritis.